Microbot Medical INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a passive beneficial ownership of 8.2% in Microbot Medical Inc. common stock.
NASDAQ
Intracoastal Capital LLC and its affiliates have reported a 0% beneficial ownership in Microbot Medical Inc. common stock, excluding a warrant exercisable in March 2026.
NASDAQ
The Vanguard Group has reported a reduced beneficial ownership in Microbot Medical Inc., now holding 4.45% of common stock.
NASDAQ
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a 9.99% beneficial ownership stake in Microbot Medical Inc. as of June 30, 2025.
NASDAQ
The Vanguard Group has reported a beneficial ownership of 5.63% in Microbot Medical Inc.'s common stock as of June 30, 2025.
NASDAQ
CVI Investments, Inc. and Heights Capital Management, Inc. have jointly disclosed a beneficial ownership of 4.9% in Microbot Medical Inc., totaling 1,824,807 shares.
NASDAQ
SCHEDULE 13G/A: Intracoastal Capital and Affiliates Report 6.3% Beneficial Ownership in Microbot Medical Inc.
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has filed an amended Schedule 13G reporting a 6.3% beneficial ownership stake in Microbot Medical Inc. as of March 31, 2025.
NASDAQ
CVI Investments, Inc. and Heights Capital Management, Inc. have jointly reported a 6.1% beneficial ownership stake in Microbot Medical Inc., totaling 1,257,143 shares.
NASDAQ
SCHEDULE 13G: Intracoastal Capital and Affiliates Disclose Increased Passive Stake in Microbot Medical Inc. to 8.8%
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has disclosed a passive beneficial ownership of 8.8% in Microbot Medical Inc. as of January 10, 2025.